SecBot SecBot
PRESS-RELEASE ·Filed Mar 30, 2026

BGMS

Bio Green Med Solution, Inc.
MIXED
Impact 5/10
Horizonweeks Processed7mo ago WireGlobeNewswire
Press release · Earnings
Actionable Insight ◆ Mixed

The stock may react positively to the narrowed net loss and strategic clarity, but traders should be cautious — the improvement is driven by one-time gains, not operating performance. Monitor whether fire safety revenue can scale meaningfully in 2026 and if G&A costs normalize. Liquidity is tight with only $3.5M cash supporting ongoing operations.

DirectionMixed
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
BGMS ▼ -39.90% at T+60d
NEUTRAL call -39.90% · α vs SPY -52.28% · entry $1.00 → $0.6010
Entry = T+0 close
Mar 30, 2026
via day close
T+1d
-1.00%
call -1.00% · α -1.75%
$0.9900
settled 7mo ago
T+5d
-1.00%
call -1.00% · α -4.94%
$0.9900
settled 7mo ago
T+20d
-4.00%
call -4.00% · α -13.42%
$0.9600
settled 6mo ago
T+60d
-39.90%
call -39.90% · α -52.28%
$0.6010
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Bio Green Med Solution (BGMS) reported a strategic pivot from biopharma to fire safety operations following the acquisition of Fitters Sdn. Bhd. in September 2025. While total net loss narrowed from $11.2M to $3.0M year-over-year due to asset sales and deconsolidation gains, core operating performance remains weak with minimal revenue ($747K) and continued losses. The company's transformation is reflected in zero R&D spend and a shift in asset base, but underlying operations are not yet profitable.

Key Financial Metrics

Revenue
$747.0K
EPS
$-6.45
Deal Value
$300.0K

Key Facts

  • Completed acquisition of Fitters Sdn. Bhd. on September 12, 2025, shifting focus to fire safety protection and distribution
  • Reported $747K in product revenue from fire safety for full year 2025, with $666K in Q4
  • Net loss narrowed to $3.0M in 2025 from $11.2M in 2024, primarily due to $4.9M gain on deconsolidation of UK subsidiary and $300K from plogosertib asset sale
  • R&D expenses dropped to $0 in Q4 and $848K for full year 2025 vs $6.7M in 2024, reflecting exit from biopharma operations
  • Cash and cash equivalents were $3.5M as of December 31, 2025, down from $3.8M, with estimated runway into Q3 2026
  • General and administrative expenses rose to $7.7M in 2025 from $5.4M in 2024 due to one-time costs from two control changes

Financial Impact

Revenue of $747K with net loss of $3.0M; $4.9M gain on deconsolidation inflated profitability. Core operations generated negative cash flow despite reduced R&D.

revenuenet losscash flowR&D expenseG&A

Risk Factors

  • Core operations remain unprofitable with minimal revenue generation
  • Cash runway extends only into Q3 2026, raising potential dilution risk
  • Significant one-time gains mask weak underlying performance
  • Two changes in control during 2025 suggest governance instability

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3265028
7 reports for BGMS
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for BGMS — sortable, filterable
TypeNow
Oct 23, 2026
3d ago
S-3
BEARISH ★ 7/10
$0.9050awaiting T+20—$0.9500 (−4.97%)
Oct 16, 2026
10d ago
8-K
NEUTRAL ★ 2/10
$0.9329awaiting T+20—$0.9500 (+1.83%)
Oct 9, 2026
17d ago
EFFECT
NEUTRAL ★ 4/10
$0.8490awaiting T+20—$0.9500 (+11.90%)
Aug 13, 2026
10w ago
8-K
BEARISH ★ 8/10
$0.9150 $0.8976▲ +1.90%▼ −0.09%$0.9500 (−3.83%)
Jul 24, 2026
13w ago
S-4/A
BEARISH ★ 8/10
$0.9249 $0.8705▲ +5.88%▲ +9.18%$0.9500 (−2.71%)
Jun 4, 2026
20w ago
Press Release
NEUTRAL ★ 5/10
$1.50 $0.9398▼ −37.35%▼ −39.21%$0.9500 (−36.67%)
Mar 30, 2026
30w ago
Press Release
MIXED ★ 5/10
$1.00 $0.9600▼ −4.00%▼ −13.42%$0.9500 (−5.00%)
Showing 7 of 7

US Market Status

Market Closed — Opens Wed (11h 51m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 30, 2026